Endogenous BTG2 expression stimulates migration of bladder cancer cells and correlates with poor clinical prognosis for bladder cancer patients

The B-cell translocation gene 2 (BTG2) is considered to act as a tumour-suppressor gene because of its antiproliferative and antimigratory activities. Higher levels of BTG2 expression in tumour cells have been linked to a better clinical outcome for several cancer entities. Here, we investigated the...

Full description

Bibliographic Details

Main Authors:	Wagener, Nina (Author) , Bulkescher, J. (Author) , Macher-Göppinger, Stephan (Author) , Karapanagiotou-Schenkel, Irini (Author) , Hatiboglu, Gencay (Author) , Abdel-Rahim, M. (Author) , Abol- Enein, H. (Author) , Ghoneim, M. A. (Author) , Bastian, P. J. (Author) , Müller, S. C. (Author) , Haferkamp, A. (Author) , Hohenfellner, Markus (Author) , Hoppe-Seyler, Felix (Author) , Hoppe-Seyler, Karin (Author)
Format:	Article (Journal)
Language:	English
Published:	8 January 2013
In:	British journal of cancer Year: 2013, Volume: 108, Issue: 4, Pages: 973-982
ISSN:	1532-1827
DOI:	10.1038/bjc.2012.573
Online Access:	Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1038/bjc.2012.573 Verlag, lizenzpflichtig, Volltext: https://www.nature.com/articles/bjc2012573
Author Notes:	N. Wagener, J. Bulkescher, S. Macher-Goeppinger, I. Karapanagiotou-Schenkel, G. Hatiboglu, M. Abdel-Rahim, H. Abol- Enein, M.A. Ghoneim, P.J. Bastian, S.C. Müller, A. Haferkamp, M. Hohenfellner, F. Hoppe-Seyler and K. Hoppe-Seyler